Opus Genetics (IRD) Share-based Compensation Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.70% |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | 60.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.35% |
| Dec 31, 2025 | -179.85% |
| Jun 30, 2025 | 11.17% |
| Mar 31, 2025 | 272.65% |
| Dec 31, 2024 | 344.73% |
| Jun 30, 2024 | -43.32% |
| Mar 31, 2024 | -99.90% |
| Dec 31, 2023 | 157.85% |
| Sep 30, 2023 | 478.79% |
| Jun 30, 2023 | 219.55% |
| Mar 31, 2023 | 55,405.62% |
| Dec 31, 2022 | -356.58% |
| Sep 30, 2022 | 280.77% |
| Jun 30, 2022 | 1,434.48% |
| Mar 31, 2022 | -9.92% |
| Dec 31, 2021 | -6.63% |
| Sep 30, 2021 | -95.78% |
| Jun 30, 2021 | -90.82% |
| Mar 31, 2021 | 709.84% |
| Dec 31, 2020 | 819.01% |
| Sep 30, 2020 | 579.20% |
| Jun 30, 2020 | 147.55% |
| Mar 31, 2020 | -62.11% |
| Dec 31, 2019 | 91.33% |
| Sep 30, 2019 | -67.78% |
| Jun 30, 2019 | -52.22% |
| Mar 31, 2019 | -45.71% |
| Dec 31, 2018 | -423.64% |
| Sep 30, 2018 | 23.67% |
| Jun 30, 2018 | -7.26% |
| Mar 31, 2018 | 8.11% |
| Dec 31, 2017 | -80.63% |
| Sep 30, 2017 | -38.38% |
| Jun 30, 2017 | -17.97% |
| Mar 31, 2017 | -20.02% |
| Dec 31, 2016 | 40.20% |
| Sep 30, 2016 | 63.95% |
| Jun 30, 2016 | 29.12% |
| Mar 31, 2016 | 509.80% |
| Dec 31, 2015 | 406.50% |
| Sep 30, 2015 | 38.07% |
| Jun 30, 2015 | 105.23% |
| Mar 31, 2015 | -56.17% |
| Dec 31, 2014 | 158.77% |
| Sep 30, 2014 | 141.00% |
| Jun 30, 2014 | 143.73% |
| Mar 31, 2014 | -65.49% |
| Dec 31, 2013 | 150.93% |
| Sep 30, 2013 | 11.72% |
| Jun 30, 2013 | 7.13% |
| Mar 31, 2013 | 307.96% |
| Dec 31, 2012 | -77.30% |
| Sep 30, 2012 | -57.04% |
| Jun 30, 2012 | -70.18% |
| Mar 31, 2012 | -54.86% |
| Dec 31, 2011 | 111.61% |
| Sep 30, 2011 | -89.47% |